BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 22411304)

  • 1. Correlations between diffusion-weighted imaging and breast cancer biomarkers.
    Martincich L; Deantoni V; Bertotto I; Redana S; Kubatzki F; Sarotto I; Rossi V; Liotti M; Ponzone R; Aglietta M; Regge D; Montemurro F
    Eur Radiol; 2012 Jul; 22(7):1519-28. PubMed ID: 22411304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes.
    Youk JH; Son EJ; Chung J; Kim JA; Kim EK
    Eur Radiol; 2012 Aug; 22(8):1724-34. PubMed ID: 22527371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histogram analysis of apparent diffusion coefficient at 3.0t: Correlation with prognostic factors and subtypes of invasive ductal carcinoma.
    Kim EJ; Kim SH; Park GE; Kang BJ; Song BJ; Kim YJ; Lee D; Ahn H; Kim I; Son YH; Grimm R
    J Magn Reson Imaging; 2015 Dec; 42(6):1666-78. PubMed ID: 25919239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR mammography using diffusion-weighted imaging in evaluating breast cancer: a correlation with proliferation index.
    Molinari C; Clauser P; Girometti R; Linda A; Cimino E; Puglisi F; Zuiani C; Bazzocchi M
    Radiol Med; 2015 Oct; 120(10):911-8. PubMed ID: 25776017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
    Horvat JV; Bernard-Davila B; Helbich TH; Zhang M; Morris EA; Thakur SB; Ochoa-Albiztegui RE; Leithner D; Marino MA; Baltzer PA; Clauser P; Kapetas P; Bago-Horvath Z; Pinker K
    J Magn Reson Imaging; 2019 Sep; 50(3):836-846. PubMed ID: 30811717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Added value of mean and entropy of apparent diffusion coefficient values for evaluating histologic phenotypes of invasive ductal breast cancer with MR imaging.
    Suo S; Zhang D; Cheng F; Cao M; Hua J; Lu J; Xu J
    Eur Radiol; 2019 Mar; 29(3):1425-1434. PubMed ID: 30116958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is simultaneous multi-slice readout-segmented echo-planar imaging valuable for predicting molecular subtypes of breast cancer?
    Li X; Zhu H; Sun K; Chai W; Fu C; Yan F
    Eur J Radiol; 2022 May; 150():110232. PubMed ID: 35259708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.
    Richard R; Thomassin I; Chapellier M; Scemama A; de Cremoux P; Varna M; Giacchetti S; Espié M; de Kerviler E; de Bazelaire C
    Eur Radiol; 2013 Sep; 23(9):2420-31. PubMed ID: 23652844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent diffusion coefficient cannot predict molecular subtype and lymph node metastases in invasive breast cancer: a multicenter analysis.
    Surov A; Chang YW; Li L; Martincich L; Partridge SC; Kim JY; Wienke A
    BMC Cancer; 2019 Nov; 19(1):1043. PubMed ID: 31690273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion Kurtosis MR Imaging of Invasive Breast Cancer: Correlations With Prognostic Factors and Molecular Subtypes.
    Kang HS; Kim JY; Kim JJ; Kim S; Lee NK; Lee JW; Suh HB; Hwangbo L; Son Y; Grimm R
    J Magn Reson Imaging; 2022 Jul; 56(1):110-120. PubMed ID: 34792837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes.
    Leithner D; Bernard-Davila B; Martinez DF; Horvat JV; Jochelson MS; Marino MA; Avendano D; Ochoa-Albiztegui RE; Sutton EJ; Morris EA; Thakur SB; Pinker K
    Mol Imaging Biol; 2020 Apr; 22(2):453-461. PubMed ID: 31209778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: Associations between quantitative MR parameters and Ki-67 proliferation status.
    Shin JK; Kim JY
    J Magn Reson Imaging; 2017 Jan; 45(1):94-102. PubMed ID: 27313102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted MRI of estrogen receptor-positive, HER2-negative, node-negative breast cancer: association between intratumoral heterogeneity and recurrence risk.
    Kim JY; Kim JJ; Hwangbo L; Lee JW; Lee NK; Nam KJ; Choo KS; Kang T; Park H; Son Y; Grimm R
    Eur Radiol; 2020 Jan; 30(1):66-76. PubMed ID: 31385051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery.
    Pata G; Guaineri A; Bianchi A; Amoroso V; Pasinetti N; Pasini M
    J Surg Res; 2019 Apr; 236():288-299. PubMed ID: 30694768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of dynamic contrast-enhanced MRI and diffusion-weighted MR imaging with prognostic factors and subtypes of breast cancers.
    Chen H; Li W; Wan C; Zhang J
    Front Oncol; 2022; 12():942943. PubMed ID: 35992872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of breast cancer subtypes based on quantitative assessment of intratumoral heterogeneity using dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging.
    Kim JJ; Kim JY; Suh HB; Hwangbo L; Lee NK; Kim S; Lee JW; Choo KS; Nam KJ; Kang T; Park H
    Eur Radiol; 2022 Feb; 32(2):822-833. PubMed ID: 34345946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of the apparent diffusion coefficiency values on diffusion-weighted imaging with prognostic factors for breast cancer.
    Choi SY; Chang YW; Park HJ; Kim HJ; Hong SS; Seo DY
    Br J Radiol; 2012 Aug; 85(1016):e474-9. PubMed ID: 22128125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations between apparent diffusion coefficient values and prognostic factors of breast cancer.
    Kamitani T; Matsuo Y; Yabuuchi H; Fujita N; Nagao M; Jinnouchi M; Yonezawa M; Yamasaki Y; Tokunaga E; Kubo M; Yamamoto H; Yoshiura T; Honda H
    Magn Reson Med Sci; 2013; 12(3):193-9. PubMed ID: 23857151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors.
    Kim SH; Cha ES; Kim HS; Kang BJ; Choi JJ; Jung JH; Park YG; Suh YJ
    J Magn Reson Imaging; 2009 Sep; 30(3):615-20. PubMed ID: 19711411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a correlation between 3T multiparametric MRI and molecular subtypes of breast cancer?
    Montemezzi S; Camera L; Giri MG; Pozzetto A; Caliò A; Meliadò G; Caumo F; Cavedon C
    Eur J Radiol; 2018 Nov; 108():120-127. PubMed ID: 30396643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.